Marina Kremyanskaya, MD PhD
img_Marina Kremyanskaya
ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
Are you a patient?
Specialties
Internal Medicine, Hematology-Oncology, Cancer (Oncology)
Research Topics
Cancer, Leukemia

MD, Perelman School Of Medicine At The University Of Pennsylvania

Residency, Internal Medicine, Mount Sinai Hospital

Fellowship, Hematology & Oncology, Mount Sinai Hospital

Certifications

American Board of Internal Medicine
Publications

Selected Publications

Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia. Metodi Balev, Victor Zibara, Grace Van Hyfte, Jonathan Feld, Marina Kremyanskaya, Michelle Becker, Alla Keyzner, Alan H. Shih, Bridget Marcellino, Hannah Levavi, Lewis Silverman, John Mascarenhas, Douglas Tremblay. American Journal of Hematology

Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial. Eunice S. Wang, Ghayas C. Issa, Harry P. Erba, Jessica K. Altman, Pau Montesinos, Stephane DeBotton, Roland B. Walter, Kristen Pettit, Michael R. Savona, Mithun Vinod Shah, Marina Kremyanskaya, Maria R. Baer, James M. Foran, Gary Schiller, Lionel Adès, Mael Heiblig, Celine Berthon, Pierre Peterlin, Eduardo Rodríguez-Arbolí, Olga Salamero, Mrinal M. Patnaik, Cristina Papayannidis, Jolanta Grembecka, Tomasz Cierpicki, Bradley Clegg, Joshua Ray, Brian M. Linhares, Kun Nie, Amitava Mitra, Julie Mackey Ahsan, Marilyn Tabachri, Harris S. Soifer, Daniel Corum, Mollie Leoni, Stephen Dale, Amir T. Fathi. The Lancet Oncology

Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis. Aaron T. Gerds, Claire Harrison, Jean Jacques Kiladjian, Ruben Mesa, Alessandro M. Vannucchi, Rami Komrokji, Prithviraj Bose, Marina Kremyanskaya, Adam J. Mead, Jason Gotlib, Shelonitda Rose, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Jeanne M. Palmer, Kelly McCaul, Vincent Ribrag, Francesco Passamonti. Blood advances

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Kremyanskaya during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Protagonist Therapeutics, Inc.
  • Silence Therapeutics
  • Constellation
  • Disc Medicine, Inc.
  • Incyte Corporation
  • CTI
  • Agios pharmaceuticals
  • AbbVie Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.